First American Trust’s Quest Diagnostics DGX Stock Holding History

First American Trust’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$405K	Sell	1,910 -3	-0.2%	-$589	0.02%	223
2026 Q1	$375K	Buy	1,913 +16	+0.8%	+$3.11K	0.03%	211
2025 Q4	$329K	Hold	1,897	–	–	0.02%	224
2025 Q3	$362K	Buy	1,897 +699	+58%	+$124K	0.03%	195
2025 Q2	$215K	Buy	1,198 +1	+0.1%	+$174	0.02%	223
2025 Q1	$203K	Buy	+1,197	New	+$197K	0.02%	223
2022 Q1	–	Sell	-1,191	Closed	-$206K	–	169
2021 Q4	$206K	Buy	+1,191	New	+$181K	0.03%	156
2019 Q3	–	Sell	-3,723	Closed	-$379K	–	128
2019 Q2	$379K	Buy	3,723 +15	+0.4%	+$1.44K	0.08%	92
2019 Q1	$333K	Buy	3,708 +16	+0.4%	+$1.39K	0.07%	92
2018 Q4	$307K	Sell	3,692 -777	-17%	-$72.8K	0.08%	91
2018 Q3	$482K	Buy	4,469 +8	+0.2%	+$877	0.11%	84
2018 Q2	$490K	Buy	4,461 +16	+0.4%	+$1.67K	0.12%	91
2018 Q1	$446K	Buy	4,445 +13	+0.3%	+$1.33K	0.11%	92
2017 Q4	$436K	Buy	4,432 +17	+0.4%	+$1.61K	0.11%	89
2017 Q3	$413K	Buy	4,415 +20	+0.5%	+$2.12K	0.11%	83
2017 Q2	$489K	Buy	4,395 +14	+0.3%	+$1.48K	0.14%	83
2017 Q1	$430K	Sell	4,381 -8	-0.2%	-$763	0.13%	80
2016 Q4	$403K	Buy	4,389 +42	+1%	+$3.62K	0.12%	83
2016 Q3	$368K	Buy	4,347 +1,211	+39%	+$102K	0.11%	86
2016 Q2	$255K	Buy	3,136 +19	+0.6%	+$1.45K	0.09%	91
2016 Q1	$223K	Buy	+3,117	New	+$209K	0.08%	97

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

First American Trust's DGX Position: Q2 2026 in Review

First American Trust reduced its Quest Diagnostics (DGX) stake by 0.16% in Q2 2026, selling an estimated $589 and leaving 1,910 shares worth $405K. The position accounts for 0.02% of the portfolio, ranked #223.

First American Trust first reported a position in DGX in Q1 2016 and has held it in 21 quarters since. The position peaked at $490K in Q2 2018. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

First American Trust held 1,910 shares of Quest Diagnostics worth $405K as of Q2 2026.
First American Trust sold 3 Quest Diagnostics shares in Q2 2026, an estimated $589.
Quest Diagnostics made up 0.02% of First American Trust's portfolio in Q2 2026, its #223 holding.
First American Trust first reported a position in Quest Diagnostics in Q1 2016 and has held it in 21 quarters since.
First American Trust's Quest Diagnostics position peaked at $490K in Q2 2018.
1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on First American Trust's 13F filing for Q2 2026, filed 10 Aug 2026.